The Interchangeability of Innovator and Generic Drugs

MOJ Bioequivalence & Bioavailability
doi 10.15406/mojbb.2017.03.00022
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MedCrave Group, LLC

Related search

Towards Understanding Interchangeability of Generic Drugs

English

Interchangeability of Generic Drugs: A Non-Parametric Pharmacokinetic Model of Gabapentin Generic Drugs

Clinical Pharmacology and Therapeutics
Pharmacology
2018English

The Concept Of: Generic Drugs and Patented Drugs vs. Brand Name Drugs and Non-Proprietary (Generic) Name Drugs

Frontiers in Pharmacology
Pharmacology
2013English

Generic Drugs: The Authors Reply

Health Affairs
MedicineHealth Policy
2011English

Remaking the Innovator Imperative

2019English

France to Promote Sales of Generic Drugs

BMJ
2001English

Comparative Study of Drug Efficacy and Drug Additives Between Generic Drugs and Original Drugs

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2007English

Availability and Interchangeability of Metals

1976English

The Performance of Gatekeepers in Innovator Networks

Industry and Innovation
AccountingManagement of TechnologyManagementBusinessInnovation
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy